De León-Nava Marco A, Romero-Núñez Eunice, Luna-Nophal Angélica, Bernáldez-Sarabia Johanna, Sánchez-Campos Liliana N, Licea-Navarro Alexei F, Morales-Montor Jorge, Muñiz-Hernández Saé
Departamento de Innovación Biomédica, Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE), Baja California, C.P. 22860, Mexico.
Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Secretaría de Salud, San Fernando No. 22, Col. Sección XVI, Tlalpan, Ciudad de Mexico, C.P. 14080, Mexico.
Mar Drugs. 2016 Apr 8;14(4):66. doi: 10.3390/md14040066.
Toxins that are secreted by cone snails are small peptides that are used to treat several diseases. However, their effects on parasites with human and veterinary significance are unknown. Toxoplasma gondii is an opportunistic parasite that affects approximately 30% of the world's population and can be lethal in immunologically compromised individuals. The conventional treatment for this parasitic infection has remained the same since the 1950s, and its efficacy is limited to the acute phase of infection. These findings have necessitated the search for new drugs that specifically target T. gondii. We examined the effects of the synthetic toxin cal14.1a (s-cal14.1a) from C. californicus on the tachyzoite form of T. gondii. Our results indicate that, at micromolar concentrations, s-cal14.1a lowers viability and inhibits host cell invasion (by 50% and 61%, respectively) on exposure to extracellular parasites. Further, intracellular replication decreased significantly while viability of the host cell was unaffected. Our study is the first report on the antiparasitic activity of a synthetic toxin of C. californicus.
锥螺分泌的毒素是用于治疗多种疾病的小肽。然而,它们对具有人类和兽医意义的寄生虫的影响尚不清楚。刚地弓形虫是一种机会性寄生虫,感染了世界上约30%的人口,在免疫功能低下的个体中可能致命。自20世纪50年代以来,这种寄生虫感染的传统治疗方法一直没有改变,其疗效仅限于感染的急性期。这些发现使得有必要寻找专门针对刚地弓形虫的新药。我们研究了来自加州锥螺的合成毒素cal14.1a(s-cal14.1a)对刚地弓形虫速殖子形式的影响。我们的结果表明,在微摩尔浓度下,s-cal14.1a在暴露于细胞外寄生虫时会降低活力并抑制宿主细胞入侵(分别降低50%和61%)。此外,细胞内复制显著减少,而宿主细胞的活力未受影响。我们的研究是关于加州锥螺合成毒素抗寄生虫活性的首次报道。